Inside Strokecheck's mysterious rise and fall

A pharmacy-based stroke screening program has been shelved amid claims patients would have unnecessary ultrasounds and be scared by inaccurate results.

Strokecheck, a charity, courted controversy when it teamed up with pharmacy giant Amcal earlier this year, announcing a plan to set up temporary in-pharmacy clinics where GPs would assess people for stroke risk and order on-the-spot carotid artery ultrasounds if deemed necessary.

Now Amcal, which in late March was still defending its decision to partner with Strokecheck, has pulled the